Information provided on this website is for educational purposes only. Always consult your Doctor, Pharmacist or Nurse for medical advice.
Published on Aug 9th, 2024
Authored by Pfizer Medical Team
Multiple myeloma is a complex blood cancer affecting over 20,000 Australians.1 Learn about symptoms, causes, risk factors and how the disease is diagnosed and treated.
Multiple myeloma, also known as myeloma, is a type of blood cancer. It affects a specific type of white blood cells called plasma cells. Plasma cells are produced in the bone marrow (the soft spongy tissue inside of the bones) and play a crucial role in the body’s immune system.1 The bone marrow produces all of the body’s blood cells; these include red blood cells, white blood cells and platelets.1
Plasma cells make antibodies to help your body fight off infections in response to bacteria, viruses and other harmful substances found in the body. 2 In multiple myeloma, abnormal plasma cells multiply rapidly, crowding out healthy plasma cells and reducing their production. Instead of producing infection-fighting antibodies, the malignant plasma cells produce abnormal proteins called monoclonal proteins (M-proteins or paraproteins), the hallmark characteristic of multiple myeloma.1,2
Multiple myeloma often affects multiple areas of the body with most people having multiple bone lesions (areas of bone damage) at the time of diagnosis.2 This is why it is called multiple myeloma.2 Common sites for bone lesions include the spine, skull, shoulders, ribs and hips.1
Multiple myeloma is considered a chronic disease and although research has significantly improved the prognosis—or predicted course of the disease, multiple myeloma remains incurable.1
Multiple myeloma is a rare cancer worldwide, but it is a common blood cancer with an estimated 176,404 people diagnosed.3 In Australia, it accounts for 15% of blood cancers and 1% of all cancers.1
Australia has one of the highest age-standardized incidence rates of multiple myeloma globally.4 In 2022, there were around 2,625 new cases, making up an estimated 1.6% of all new cancer cases diagnosed that year.5 The incidence rate has slightly increased over the years, with an estimated 7.9 cases per 100,000 Australians in 2022 compared to 7.6 cases per 100,000 in 2018.5
In 2022, multiple myeloma caused around 1,100 deaths, contributing to an estimated 2.2% of all cancer-related deaths.5
Although multiple myeloma can affect people of any age, it is more common in older patients, with incidence increasing with age.1 It is also slightly more common in men than in women.1 In 2022, it was estimated that Australians have a 1 in 111 (or 0.90%) risk of being diagnosed with multiple myeloma by the age of 85 with a slighter higher risk for males (1 in 94 or 1.1%) vs females (1 in 135 or 0.74%).5 In 2022, in Australia, there were 1,540 new cases of multiple myeloma in males vs 1,085 new cases females.5
Despite research efforts by scientists, the exact cause of multiple myeloma is still unknown.1 Like other cancers, multiple myeloma begins with one plasma cell undergoing changes that make it abnormal.6
A link has been demonstrated between multiple myeloma and a non-cancerous condition called monoclonal gammopathy of undetermined significance (MGUS).1,6 MGUS has no associated symptoms, but there is a 1% chance each year of follow-up for people with MGUS developing active multiple myeloma.1
A risk factor is anything that can increase a person's chance of getting a disease such as multiple myeloma. Although the causes of multiple myeloma are not fully understood, there are some risk factors that increase the likelihood of developing multiple myeloma.7
Some of the risk factors include: 6,7
Exposure to certain chemicals, high dose radiation and some viruses that weaken the immune system
Increasing age – most people with myeloma are diagnosed when they are over 60 years
Sex – men are slightly more likely to develop myeloma then women
Race – black people are more likely to develop this disease than those of other races
Other plasma cell diseases such as MGUS or a solitary plasmacytoma (a single tumour of plasma cells)
Family history (rare) – e.g. if a close relative (parent or sibling) has the disease, your risk is higher
Being overweight or obese
Not everyone with one or more of these risk factors will develop the disease. Speak to your doctor or a healthcare professional if you are concerned about your risk.
Signs and symptoms of multiple myeloma depend on the stage of disease, that is, how advanced the cancer has progressed.2 Typically, this cancer damages bones and affects production of healthy blood cells, leading to symptoms.
In the early stages, myeloma may not cause any noticeable symptoms, but could be detected in a routine blood test.2 In more advanced stages, multiple myeloma can cause a wide range of signs and symptoms.
Common signs and symptoms of multiple myeloma include:2,8
Persistent and recurrent bone pain and increased risk of fractures;
Persistent or worsening fatigue (tiredness), weakness, and shortness of breath – usually due to decreased production of red blood cells (anaemia) caused by the disease;
Increased thirst, abdominal pain, increased urinary frequency, nausea or vomiting, poor appetite and constipation – due to the bone destruction which increases the level of calcium in the blood (hypercalcaemia);
Blurred vision, confusion, headache, and dizziness – caused by hyperviscosity (overly thickening of the blood);
Frequent or repeated infections - due to the low white blood cell count and decreased ability of the immune system to effectively fight infections (read more about multiple myeloma and infections here);
Easy bruising and bleeding (such as frequent bleeding from the nose and gum, and heavy menstrual periods) – due to very low platelet count (thrombocytopenia);
Leg swelling or reduction in the amount of urine – due to kidney problems; meaning that the kidneys are unable to properly filter waste and excess fluids from the blood. Most patients with kidney disease do not have any symptoms until the kidneys are severely impaired;
Appetite changes and weight loss – due to high levels of calcium levels in the blood and/or kidney disease.
Speak with your doctor or healthcare professional if you are experiencing any of these symptoms.
There is currently no routine screening in place for multiple myeloma in Australia.9
Diagnosis involves your doctor performing a variety of tests including physical examination, blood and urine tests, imaging studies, bone marrow tests, and tests to assess the kidney function. These tests gather information to help confirm the diagnosis of multiple myeloma and determine what stage the disease is at.10,11
Some of these tests and examinations include:10,11
Blood tests – to count the number of red and white blood cells (i.e. complete blood cell count) and to detect and measure the presence of abnormal antibodies that the multiple myeloma cells produce;
Urine tests – to assess for presence of specific paraprotein in the urine;
X-rays and imaging scans – to assess if there is any bone damage caused by the multiple myeloma cells:
Computed tomography (CT) and radiography – imaging tests that produce more detailed, three-dimensional visualization of possible bone damage resulting from the disease;
Magnetic resonance imaging (MRI) – uses radio waves and powerful magnets to produce detailed images of bones and spine;
Bone marrow biopsy – to examine cells in the bone marrow and test for genetic changes.
These tests are fundamental for the diagnosis of multiple myeloma, in addition to helping to determine the stage of the disease, so that the most appropriate treatment can be defined.
Knowing the specific stage of the disease is crucial to help doctors know how serious the cancer is. Staging provides valuable information about the prognosis and helps determine the treatment approach.2 Multiple myeloma can be categorized into different stages based on the severity of the disease and how the disease is distributed in the body.2 The International Staging System (ISS) classifies myeloma into three stages:2
Stage I: Early disease
Stage II: In between Stage I and Stage III
Stage III: Advanced disease
CRAB criteria is commonly used to determine if a person has active myeloma that requires treatment. CRAB stands for: increased calcium level (C), renal (kidney) problems (R), anaemia (A), and bone changes (lytic lesions or bone loss) (B).2 The presence of one or more of these symptoms indicates symptomatic myeloma, which requires treatment.2
If an increased number of plasma cells is detected in your bone marrow, but you do not have symptoms or not meet the criteria for a multiple myeloma diagnosis, your condition may be classified as either "MGUS" or "smouldering myeloma".2
These two conditions are also sometimes referred to as pre-myeloma stages:2
Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic non-cancerous plasma cell condition. It involves the production of paraprotein by plasma cells but does not cause any symptoms. MGUS is typically detected during routine blood or urine tests, and individuals with MGUS do not require immediate treatment. Instead, regular follow-up with a doctor is recommended to monitor protein levels. In some cases, individuals with MGUS may develop myeloma over time. Not everyone who has MGUS will progress to develop multiple myeloma.2
Smouldering myeloma is an early phase of multiple myeloma that does not exhibit any symptoms, but a bone marrow biopsy confirms the presence of multiple myeloma cells. Treatment is not immediately necessary for individuals diagnosed with smouldering myeloma. Instead, treatment is initiated at a later stage when the disease progresses after several months or years.
Multiple myeloma does not commonly cause tumours outside of the bone marrow, but when it does, its’ called extramedullary disease.12 This is a particularly aggressive form of multiple myeloma.12
Some of the typical sites for multiple myeloma to be found outside the bone are:12
skin and soft tissues
liver
kidneys
lymph nodes
central nervous system
breast
lung
heart
Since the exact cause of multiple myeloma is unknown, there are currently no known ways to prevent this disease from developing.13 However, some risk factors can be avoided, such as exposure to certain chemicals or high-dose radiation in the work-place.13
Treatment for multiple myeloma aims to control the disease (stop its progression) and improve overall quality of life, as there is currently no cure.1,14
Treatment is typically recommended during the active phases of the disease and will continue until your multiple myeloma has stopped progressing or is no longer detected.1 With newer treatments, it is possible for multiple myeloma to be controlled for many years.14
While there are several types of treatment now available, the type of treatment you will receive (if any) will depend on:14,15
Treatment options for multilpe myeloma may include:14,15
Learn more about different types of cancer treatment here.
Research is ongoing in this space to constantly develop improved treatments. In some cases, your doctor may suggest you enter a clinical trial to receive the latest experimental treatment with drugs not yet available for general use.14
Read more about clinical trials in multiple myeloma here.
Getting a cancer diagnosis brings about a lot of emotions and sharing your diagnosis can be challenging.
Whether you receive a treatment or not, or even if your treatment has ended, you will need to have regular check-ups with your doctor to make sure that the disease is not progressing (getting worse), or returning (relapse).14
Each type of treatment has a different recovery journey, and some treatments have long-term side effects.16
Living with multiple myeloma can also affect your mental health and general wellbeing. It is important to incorporate a healthy diet and exercise (where possible) to help manage the physical and mental symptoms.16
If you are finding it hard to cope, or are struggling with symptoms or treatment, be sure to talk to your doctor or find a support group. There are many sources of support and information available to you.
The prognosis (outlook) and rates of survival for patients with multiple myeloma cancer vary depending on several factors including the stage of the disease, response to treatment, age and overall general health.9 Early-stage multiple myeloma generally has a better prognosis and survival rate compared to more advanced cancer that has spread.16
With treatments constantly improving, multiple myeloma may be controlled for several years.9
In Australia, the survival rate for multiple myeloma has improved over time.5 There was an increase in the 5-year survival rate up to 55% for individuals diagnosed in 2014-2018 compared with 28% for those diagnosed in the years 1989-1993.5
Your doctor will discuss your individual circumstances and prognosis with you.
Myeloma Australia. What is myeloma? https://myeloma.org.au/what-is-myeloma/ Accessed 28 May 2024
Leukaemia Foundation. What is myeloma? https://www.leukaemia.org.au/blood-cancer/types-of-blood-cancer/myeloma/ Accessed 28 May 2024
Multiple Myeloma: Statistics. American Society of Oncology. https://www.cancer.net/cancer-types/multiple-myeloma/statistics Accessed 28 May 2024
Zhou et al. Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019. BMC Cancer. 2021; 606. https://doi.org/10.1186/s12885-021-08280-y
Australian Government | Cancer Australia. Multiple myeloma in Australia statistics. https://www.canceraustralia.gov.au/cancer-types/myeloma/statistics Accessed 28 May 2024
Mayo Clinic. Multiple Myeloma. https://www.mayoclinic.org/diseases-conditions/multiple-myeloma/symptoms-causes/syc-20353378 Accessed 28 May 2024
Australian Government | Cancer Australia. What are the risk factors for myeloma? https://www.canceraustralia.gov.au/cancer-types/myeloma/awareness Accessed 28 May 2024
Signs and Symptoms of Multiple Myeloma. American Cancer Society. https://www.cancer.org/cancer/types/multiple-myeloma/detection-diagnosis-staging/signs-symptoms.html Accessed 28 May 2024
Cancer Council. Types of Cancer – Myeloma. https://www.cancer.org.au/cancer-information/types-of-cancer/myeloma Accessed 28 May 2024
Leukaemia Foundation. Myeloma diagnosis. https://www.leukaemia.org.au/blood-cancer/types-of-blood-cancer/myeloma/diagnosis/ Accessed 28 May 2024
Tests to Find Multiple Myeloma. American Cancer Society. https://www.cancer.org/cancer/types/multiple-myeloma/detection-diagnosis-staging/testing.html Accessed 28 May 2024
Blade J et al. Extramedullary disease in multiple myeloma: a systematic literature review. Blood Cancer Journal. 2000;12(3):45
Can Multiple Myeloma be Prevented? American Cancer Society. https://www.cancer.org/cancer/types/multiple-myeloma/causes-risks-prevention/prevention.html Accessed 28 May 2024
Leukaemia Foundation. Myeloma treatment. https://www.leukaemia.org.au/blood-cancer/types-of-blood-cancer/myeloma/treatment/ Accessed 28 May 2024
Myeloma Australia. How is myeloma treated? https://myeloma.org.au/what-is-myeloma/ Accessed 28 May 2024
Cancer Council. Understanding Myeloma. https://www.cancercouncil.com.au/wp-content/uploads/2022/09/Understanding-Myeloma-2022.pdf Accessed 28 May 2024